advertisement

WGC-2021

11.14 Investigational drugs; pharmacological experiments (46)

Showing records 1 to 25

Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments

Search within classification 11.14 Investigational drugs; pharmacological experiments
79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Ashwinbalaji S
Scientific reports 2018; 8: 15472
79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Komizo T
Japanese Journal of Ophthalmology 2019; 63: 40-45
79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Pitha I
Translational vision science & technology 2018; 7: 6
78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Matsou A
Expert Opinion on Investigational Drugs 2018; 27: 777-785
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Weinreb RN
Ophthalmology 2018; 125: 1874-1885
78351 Glaucoma Drugs in the Pipeline
Kaufman PL
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351
79132 Rho-kinase (ROCK) Inhibitors- A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Abbhi V
Current Medicinal Chemistry 2018; 0:
78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Moshirfar M
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Liebmann JM
Ophthalmology 2018; 125: 1874-1885
78351 Glaucoma Drugs in the Pipeline
Mohr ME
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351
79132 Rho-kinase (ROCK) Inhibitors- A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility
Piplani P
Current Medicinal Chemistry 2018; 0:
79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Ono T
Japanese Journal of Ophthalmology 2019; 63: 40-45
78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Parker L
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111
79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Oglesby E
Translational vision science & technology 2018; 7: 6
78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Anastasopoulos E
Expert Opinion on Investigational Drugs 2018; 27: 777-785
79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Senthilkumari S
Scientific reports 2018; 8: 15472
79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Chow A
Translational vision science & technology 2018; 7: 6
79189 SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes
Gowripriya C
Scientific reports 2018; 8: 15472
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Cioffi GA
Ophthalmology 2018; 125: 1874-1885
78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Birdsong OC
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111
79141 Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
Yagi A
Japanese Journal of Ophthalmology 2019; 63: 40-45
78351 Glaucoma Drugs in the Pipeline
Riccomini SP
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2018; 7: 345-351
78514 Oral Memantine for the Treatment of Glaucoma: Design and Results of 2 Randomized, Placebo-Controlled, Phase 3 Studies
Goldberg I
Ophthalmology 2018; 125: 1874-1885
79096 Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma
Kimball E
Translational vision science & technology 2018; 7: 6
78782 Use of Rho kinase Inhibitors in Ophthalmology: A Review of the Literature
Ronquillo YC
Medical hypothesis, discovery and innovation in ophthalmology 2018; 7: 101-111

Issue 20-1

Select Issue


advertisement

Oculus